SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals zooms on introducing treatment of uterine fibroids

03 Feb 2012 Evaluate

Apollo Hospitals is currently trading at Rs. 617.90, up by 21.05 points or 3.53% from its previous closing of Rs. 596.85 on the BSE.

The scrip opened at Rs. 584.05 and has touched a high and low of Rs. 622.90 and Rs. 584.05 respectively. So far 48817 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 716.90 on 05-Dec-2011 and a 52 week low of Rs. 432.30 on 24-Jun-2011.

Last one week high and low of the scrip stood at Rs. 622.90 and Rs. 584.05 respectively. The current market cap of the company is Rs. 8094.22 crore.

The promoters holding in the company stood at 33.10% while Institutions and Non-Institutions held 34.44% and 31.15% respectively.

Apollo Hospitals has rolled out an MRI-guided high intensity focused ultrasound solution from Philips Healthcare to offer non-invasive treatment of uterine fibroids in women. As per the traditional treatment, women have to undergo surgery and a long road to recovery, which takes up several months to recover. The solution is currently available in four Apollo hospitals - in Chennai, Delhi, Bangalore and Hyderabad and it plans to expand to other centers as well.

MRI-guided ultrasound solution will be helpful as it involves no radiation, no scar, no anesthesia, recovery time of just a day, more precise magnetic resonance image guided treatment. Traditional surgery costs Rs 40,000-60,000 at Apollo, the new solution will cost Rs 70,000-90,000. The cost of the Philips machine imported from Helsinki is Rs 5 crore.

Apollo Hospitals, is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.

Apollo Hospital Ent. Share Price

7732.50 -11.45 (-0.15%)
22-Apr-2026 09:35 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×